查詢結果分析
來源資料
相關文獻
- 睫狀體冷凍治療的臨床觀察
- Clinical Experience in the Management of Neovascular Glaucoma
- 睫狀體冷凍治療新生血管性青光眼的長期結果
- Corneal Opacity and Congenital Glaucoma Associated with Massive Heparan Sulfaturia: Report of One Case
- 碳酸酐酶抑制劑6-Hydroxyethoxy-2-benzothiazole Sulfonamide靜脈注射後之兔眼藥物動力學
- 碳酸酐酶抑制劑6-Hydroxyethoxyzolamide局部點眼後之兔眼藥物動力學
- Carteolol (Arteoptic[feb9])之臨床評估及心血管作用--內因性擬交感神經作用之探討
- Timoptol-XE[feb9] 及Timoptol[feb9] 用於青光眼或高眼壓症病人之比較性研究
- 抑制細胞增生藥物在青光眼濾過造口術的應用
- 雅鉻雷射虹膜穿孔術於急性隅角閉鎖性青光眼的臨床結果
頁籤選單縮合
題名 | 睫狀體冷凍治療的臨床觀察 |
---|---|
作者姓名(中文) | 孫偉棟; 謝瑞玟; | 書刊名 | 中華民國眼科醫學會雜誌 |
卷期 | 31:2 1992.06[民81.06] |
頁次 | 頁32-38 |
分類號 | 416.748 |
關鍵詞 | 睫狀體冷凍治療; 青光眼; Cyclocryotherapy; Neovascular glaucoma; Angle-closure glaucoma; Open-angle glaucoma; Phthisis bulbi; Corneal edema; |
語文 | 中文(Chinese) |
中文摘要 | 睫狀體冷凍治療一般用於末期青光眼的治療。本篇以回溯性方法探討其 臨床上的療效。本篇乃收集過去七年中在馬偕醫院接受睫狀體冷凍治療的病例, 共33位病患的33隻眼睛。其中23例為新生血管性青光眼,2例為無水晶體性青光 眼,1例為人工水晶體性青光眼,4例為隅角閉鎖性青光眼,1例為末期隅角開放 性青光眼,2例為晶體脫位續發性青光眼。追蹤期間從3個月到81個月,平均19.8 個月。術前眼壓平均48.9±12.0mmHg,術後眼壓平均31.5±17.6mmHg,平均下降 17.4mmHg。眼壓控制良好者(即眼壓低於21mmHg)佔30.6。疼痛顯著改善者佔 75.0。角膜水腫改善者佔95.5。虹彩新生血管消退者佔70.4。結果顯示睫狀體冷凍 治療可有效地改善眼球疼痛,角膜水腫及虹彩新生血管,但對眼壓的控制則不理 想。此外發生眼球萎縮者有2例。 |
英文摘要 | Cyclocryotherapy is one of the treatmentmodalities in end stage glaucoma. We evaluated itsclinical efficacy retrospectively. This study collected33 eyes of 33 patients who received cyclocryotherapyin the past 7 years at Mackay Memorial Hospital.Twenty-three eyes were enrolled into tile neovascularglaucoma group, 2 eyes into the aphakic glaucomagroup, 1 eye into the pseudophakic glaucoma group,4 eyes into the angle closure glaucoma group, 1 eyeinto the end stage open angle glaucoma group, and 2eyes into the lens-induced glaucoma group. The follow-up period ranged from 3 months to 81 months(average 19.8 months). The pre-operative intraocular pressure (IOP) averaged 48.9± 12.0mmHg, The results showed the postoperative IOP averaged 31.5± 17.6 mmHg, and the average decrease in IOP was 17.4 mmHg. Well-controlled IOP (i.e. IOP < 21 mmHg) was 30.6. Pain relief was 75.0. Improvement of corneal edema was 95.5. Regression of rubeosis iridis was 70.4. In conclusion, cyclocryotlierapy was indeed effective in pain relief, improvement of corneal edema and regression of rubeosis iridis. But the control of IOP was unsatisfactory. Furthermore, 2 cases of phthisis buibi were noted. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。